New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds ...

As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and ...

The effects of isolation extend far beyond children’s time in the hospital,” writes medical student Anna Tsioulias.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...

ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on ...

A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S.

Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of its ...

Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot ...

Eli Lilly announced a partnership with chipmaker NVIDIA on Tuesday to build what it claims will be the “most powerful supercomputer owned and operated by a pharmaceutical company.” Lilly’s technology ...